Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities
暂无分享,去创建一个
P. Payette | Marion Jurk | A. Krieg | H. Davis | J. Vollmer | C. Schetter | M. Liu | Sibylle Tluk | R. Weeratna | Meike Laucht | T. Wader | M. Jurk
[1] R. Coffman,et al. Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions , 2003, Journal of leukocyte biology.
[2] S. Akira,et al. The Roles of Toll-Like Receptor 9, MyD88, and DNA-Dependent Protein Kinase Catalytic Subunit in the Effects of Two Distinct CpG DNAs on Dendritic Cell Subsets1 , 2003, The Journal of Immunology.
[3] E. Uhlmann,et al. Recent advances in the development of immunostimulatory oligonucleotides. , 2003, Current opinion in drug discovery & development.
[4] S. Akira,et al. Cutting Edge: A Novel Toll/IL-1 Receptor Domain-Containing Adapter That Preferentially Activates the IFN-β Promoter in the Toll-Like Receptor Signaling1 , 2002, The Journal of Immunology.
[5] R. Flavell,et al. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors , 2002, Nature.
[6] Charles A. Janeway,et al. IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling , 2002, Cell.
[7] K. Ishii,et al. CpG DNA: recognition by and activation of monocytes. , 2002, Microbes and infection.
[8] R. Vabulas,et al. Bacterial CpG‐DNA and lipopolysaccharides activate Toll‐like receptors at distinct cellular compartments , 2002, European journal of immunology.
[9] H. Wagner,et al. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848 , 2002, Nature Immunology.
[10] A. Krieg,et al. Highly immunostimulatory CpG-free oligodeoxynucleotides for activation of human leukocytes. , 2002, Antisense & nucleic acid drug development.
[11] K. Ishii,et al. Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide , 2002, Journal of leukocyte biology.
[12] T. Giese,et al. Quantitative Expression of Toll-Like Receptor 1–10 mRNA in Cellular Subsets of Human Peripheral Blood Mononuclear Cells and Sensitivity to CpG Oligodeoxynucleotides1 , 2002, The Journal of Immunology.
[13] R. Seder,et al. CpG Oligodeoxynucleotides as Vaccine Adjuvants in Primates1 , 2002, The Journal of Immunology.
[14] S. Akira,et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway , 2002, Nature Immunology.
[15] R. Flavell,et al. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.
[16] K. Ishii,et al. Cutting Edge: Role of Toll-Like Receptor 9 in CpG DNA-Induced Activation of Human Cells1 , 2001, The Journal of Immunology.
[17] B. Blazar,et al. Synthetic unmethylated cytosine-phosphate-guanosine oligodeoxynucleotides are potent stimulators of antileukemia responses in naive and bone marrow transplant recipients. , 2001, Blood.
[18] S. Akira,et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[19] V. Hornung,et al. Identification of CpG oligonucleotide sequences with high induction of IFN‐α/β in plasmacytoid dendritic cells , 2001 .
[20] K. Heeg,et al. Suppressors of Cytokine Signaling (SOCS)-1 and SOCS-3 Are Induced by CpG-DNA and Modulate Cytokine Responses in APCs1 , 2001, The Journal of Immunology.
[21] S. Akira,et al. A Toll-like receptor recognizes bacterial DNA , 2000, Nature.
[22] S. Akira,et al. Recognition of CpG DNA is mediated by signaling pathways dependent on the adaptor protein MyD88 , 2000, Current Biology.
[23] S. Akira,et al. Immune Cell Activation by Bacterial Cpg-DNA through Myeloid Differentiation Marker 88 and Tumor Necrosis Factor Receptor–Associated Factor (Traf)6 , 2000, The Journal of experimental medicine.
[24] R. Purcell,et al. Delineation of a CpG Phosphorothioate Oligodeoxynucleotide for Activating Primate Immune Responses In Vitro and In Vivo1 , 2000, The Journal of Immunology.
[25] Gunther Hartmann,et al. Mechanism and Function of a Newly Identified CpG DNA Motif in Human Primary B Cells1 , 2000, The Journal of Immunology.
[26] A. Ullrich,et al. Cell type‐specific activation of mitogen‐activated protein kinases by CpG‐DNA controls interleukin‐12 release from antigen‐presenting cells , 1999, The EMBO journal.
[27] Fyaz M. D. Ismail,et al. Antagonism of immunostimulatory CpG-oligodeoxynucleotides by 4-aminoquinolines and other weak bases: mechanistic studies. , 1999, The Journal of pharmacology and experimental therapeutics.
[28] L. Manzel,et al. Lack of immune stimulation by immobilized CpG-oligodeoxynucleotide. , 1999, Antisense & nucleic acid drug development.
[29] P. Ricciardi-Castagnoli,et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.
[30] A. Krieg,et al. Cyclosporin A enhances IL-12 production by CpG motifs in bacterial DNA and synthetic oligodeoxynucleotides. , 1998, Journal of immunology.
[31] A. Krieg,et al. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. , 1998, Journal of immunology.
[32] A. Krieg,et al. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. , 1996, Journal of immunology.
[33] G. Bishop,et al. CpG motifs in bacterial DNA trigger direct B-cell activation , 1995, Nature.
[34] A. Krieg,et al. CpG motifs in bacterial DNA and their immune effects. , 2002, Annual review of immunology.
[35] K. Ishii,et al. Human Peripheral Blood Cells Differentially Recognize and Respond to Two Distinct CpG Motifs , 2001 .
[36] V. Hornung,et al. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. , 2001, European journal of immunology.
[37] H. Davis. Use of CpG DNA for enhancing specific immune responses. , 2000, Current topics in microbiology and immunology.